Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Toll-like receptors (TLRs) are the pattern recognition receptors, which are activated by foreign and host molecules in order to initiate the immune response. They play a crucial role in the regulation of innate immunity, and several studies have shown their importance in bacterial, viral, and fungal...
Main Authors: | Mariya Farooq, Maria Batool, Moon Suk Kim, Sangdun Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.756315/full |
Similar Items
-
Editorial: Updates on toll-like receptors in cancer immunity and immunotherapy
by: Bettina Hoden, et al.
Published: (2023-11-01) -
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
by: Yang Xun, et al.
Published: (2021-10-01) -
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
by: Lingling Huang, et al.
Published: (2022-06-01) -
Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling
by: Sangdun Choi, et al.
Published: (2012-11-01) -
Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
by: Mariya Farooq, et al.
Published: (2022-06-01)